Tumors that do not express VDR any more and, thus, lose their susceptibility to calcitriol might be seen as being less affected by a vitamin D-based treatment since the expected anti-tumor effect is reduced to calcitriol’s impact on fibroblasts and immune cells [94,144]. Here, VDR is linked to neoplasm.